SCHEMBL17876291

SCHEMBL17876291

c1ccc(N2Cc3ccc(-c4ccc5c(c4)oc4ccccc45)cc3-c3cc(-c4cccc5c4oc4ccccc45)ccc3C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 9/20 0.53
ALOX5 P09917 2/20 0.48
ATM Q13315 2/20 0.40
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
PIK3CD O00329 3/20 0.38
PIK3CB P42338 3/20 0.38
GGPS1 O95749 1/20 0.38
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 3/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CG P48736 2/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TP53 P04637 2/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876229 0.96 PRKDC (0.50) PRKDCALOX5ATMPRMT5WDR77
SCHEMBL17876234 0.96 PRKDC (0.50) PRKDCALOX5ATMPRMT5WDR77
SCHEMBL17876289 0.94 ALOX5 (0.53) PRKDCALOX5ATMPRMT5WDR77
SCHEMBL17876290 0.93 ALOX5 (0.48) PRKDCALOX5ATMPRMT5WDR77
SCHEMBL17876292 0.91 ALOX5 (0.48) PRKDCALOX5ATMPRMT5WDR77
SCHEMBL17876294 0.91 ALOX5 (0.48) PRKDCALOX5ATMPRMT5WDR77
SCHEMBL17876293 0.91 NPC1 (0.41) PRKDCATMMMP12MMP13NPC1
SCHEMBL17876299 0.90 PRKDC (0.42) PRKDCALOX5ATMMMP12MMP13
SCHEMBL17876227 0.90 ALOX5 (0.49) PRKDCALOX5ATMPRMT5WDR77
SCHEMBL17876242 0.89 ALOX5 (0.45) PRKDCALOX5ATMPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885ATM 1164/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885ATM 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.